PICSAR facilitates HCC progression by competitively binding miR‐588 and accordingly enhancing eukaryotic translation initiation factor 6 (EIF6)‐mediated phosphatidylinositol 3‐kinase (PI3K)/AKT/mechanistic target of rapamycin kinase (mTOR) pathway.15 Here, EIF6 is linked to hepatocellular carcinoma.